Mayne Pharma | MYX - Net Income


Mayne Pharma reported AUD-103.68M in Net Income for its fiscal semester ending in June of 2024.





Net Income Change Date
Ansell USD 88.8M 65.5M Dec/2025
Avita Medical AUD -11.62M 1.7M Dec/2025
Cochlear AUD 161.5M 69.6M Dec/2025
CSL USD 401M 96.5M Dec/2025
Healius AUD -12.8M 7.8M Dec/2024
Integral Diagnostics AUD 6.06M 72.81M Jun/2024
Medical Developments International AUD -226K 121K Dec/2025
Nanosonics AUD 9.64M 4.18M Dec/2025
Polynovo AUD 3K 9.87M Dec/2025
Ramsay Health Care AUD 152.7M 32.4M Dec/2025
ResMed USD 398.73M 6.14M Mar/2026
Sigma Healthcare AUD -6.72M 10.02M Dec/2024
Sonic Healthcare AUD 236.68M 82.29M Dec/2024
Telix Pharmaceuticals AUD 38.33M 43.16M Jun/2026